Glomerular-Tubulointerstitial Disorders
Tubulointerstitial diseases are clinically heterogeneous disorders that share similar features of tubular and interstitial injury. In severe and prolonged cases, the entire kidney may become involved, with glomerular dysfunction and even renal failure. The primary categories of tubulointerstitial disease are
- Acute tubular necrosis
- Acute or chronic tubulointerstitial nephritis
Contrast nephropathy is acute tubular necrosis caused by an iodinated radiocontrast agent.
Analgesic nephropathy is a type of chronic interstitial nephritis, and reflux nephropathy and myeloma kidney can involve chronic tubulointerstitial nephritis.
Tubulointerstitial disorders can also result from metabolic disturbances and exposure to toxins.
Pathophysiology
The kidneys are exposed to unusually high concentrations of toxins. The kidneys have the highest blood supply of all tissues (about 1.25 L/min or 25% of cardiac output), and unbound solutes leave the circulation via glomerular filtration at ≥ 100 mL/min; as a result, toxic agents are delivered at a rate 50 times that of other tissues and in much higher concentrations. When urine is concentrated, the luminal surfaces of tubular cells may be exposed to molecule concentrations 300 to 1000 times greater than those of plasma. The fine brush border of proximal tubular cells exposes an enormous surface area. A countercurrent flow mechanism increases ionic concentration of the interstitial fluid of the medulla (and thereby increases urine concentration) up to 4 times the plasma concentration.
In addition, factors can affect cellular vulnerability after exposure to toxins:
- Tubular transport mechanisms separate drugs from their binding proteins, which normally protect cells from toxicity.
- Transcellular transport exposes the interior of the cell and its organelles to newly encountered chemicals.
- Binding sites of some agents (eg, sulfhydryl groups) may facilitate entry but retard exit (eg, heavy metals).
- Chemical reactions (eg, alkalinization, acidification) may alter transport in either direction.
- Blockade of transport receptors may alter tissue exposure (eg, diuresis from blockade of adenosine A1 receptors, such as with aminophylline, may decrease exposure).
- The kidneys have the highest oxygen and glucose consumption per gram of tissue and are therefore vulnerable to toxins affecting cell energy metabolism.
Acute tubular necrosis (ATN)
Acute tubular necrosis (ATN) is kidney injury characterized by acute tubular cell injury and dysfunction. Common causes are hypotension or sepsis that causes renal hypoperfusion and nephrotoxic drugs. The condition is asymptomatic unless it causes renal failure. The diagnosis is suspected when azotemia develops after a hypotensive event, severe sepsis, or drug exposure and is distinguished from prerenal azotemia by laboratory testing and response to volume expansion. Treatment is supportive.
Analgesic nephropathy
Analgesic nephropathy is chronic tubulointerstitial nephritis caused by cumulative lifetime use of large amounts (eg, ≥ 2 kg) of certain analgesics. Patients present with kidney injury and usually non-nephrotic proteinuria and bland urinary sediment or sterile pyuria. Hypertension, anemia, and impaired urinary concentration occur as renal insufficiency develops. Papillary necrosis occurs late. Diagnosis is based on a history of analgesic use and results of noncontrast CT. Treatment is stopping the causative analgesic.
Contrast nephropathy
Contrast nephropathy is worsening of renal function after IV administration of radiocontrast and is usually temporary. Diagnosis is based on a progressive rise in serum creatinine 24 to 48 h after contrast is given. Treatment is supportive. Volume loading with isotonic saline before and after contrast administration may help in prevention.
Others
- Heavy Metal Nephropathy
- Metabolic Nephropathies
- Myeloma-Related Kidney Disease
- Tubulointerstitial Nephritis
- Vesicoureteral Reflux and Reflux Nephropathy
- Glomerulonephritis
- Acute Tubular Necrosis
- Acute Interstitial Nephritis Associated to Drugs
- Xanthogranulomatous Pyelonephritis
- Specific Renal Infections
- Chronic Infectious Tin (Chronic Pyelonephritis)
- Tin Associated with Systemic Infection
- Acute Infectious Tubulointerstitial Nephritis
- Chronic Pyelonephritis
- Acute Pyelonephritis
- Glomerulopathy
- Other Tubular Changes
- Respiratory Alkalosis
Related Conference of Glomerular-Tubulointerstitial Disorders
14th European Congress on Nephrology, Internal Medicine and Kidney Diseases
Glomerular-Tubulointerstitial Disorders Conference Speakers
Recommended Sessions
- Acute Kidney Injury
- Cardiovascular-Kidney Diseases
- Chronic Kidney Disease
- CKD -Mineral and Bone Disorders
- Diabetic Kidney Disease
- Diagnosis of Kidney Diseases
- Dialysis and Renal Care
- Drugs for Kidney Diseases
- Fluid, Electrolytes, Acid-Base Disorders
- Geriatric-Genetic Kidney Diseases
- Glomerular-Tubulointerstitial Disorders
- Kidney
- Kidney and Bladder stones
- Kidney Cancer
- Kidney Transplantation
- Nephrology Nursing
- Pediatric Nephrology
- Renal Nutrition
- Renal Pathology-Immunology
- Urology and Urinary Tract Infections
Related Journals
Are you interested in
- Acute & Chronic Kidney Injury: Mechanisms & Early Detection - Nephrologists 2026 (France)
- Acute Kidney Injury - Kidney Care 2026 (UK)
- Advanced Imaging & 3D Mapping in Renal Medicine - NEPHROLOGY ASIA 2026 (UAE)
- Aging Populations and Geriatric Epidemiology - EPIDEMIOLOGY-2026 (Netherlands)
- Artificial Intelligence in Nephrology - World Nephrology 2026 (Netherlands)
- Artificial Intelligence in Renal Diagnostics - NEPHROLOGY ASIA 2026 (UAE)
- Benign Urologic Conditions: Prostate, Bladder & Pelvic Health - Nephrologists 2026 (France)
- Biomarkers in Kidney Disease - KIDNEY MEET 2026 (UK)
- Biomarkers of Kidney Diseases - Euro Nephrology Summit 2026 (France)
- Cardio-Renal Syndrome - World Nephrology 2026 (Netherlands)
- Cardiorenal Syndrome - Euro Nephrology Summit 2026 (France)
- Cardiovascular Impact of Kidney Disease - KIDNEY MEET 2026 (UK)
- Chronic Kidney Disease - KIDNEY MEET 2026 (UK)
- Chronic Kidney Disease (CKD): Global Epidemiology & Prevention - World Nephrology 2026 (Netherlands)
- Climate Change and Environmental Health - EPIDEMIOLOGY-2026 (Netherlands)
- Clinical Nephrology - Kidney Care 2026 (UK)
- Clinical Nephrology - Euro Nephrology Summit 2026 (France)
- CRISPR Innovations in Nephrology - NEPHROLOGY ASIA 2026 (UAE)
- Critical Care Nephrology - KIDNEY MEET 2026 (UK)
- Diabetic Nephropathy - Kidney Care 2026 (UK)
- Diabetic Nephropathy - Euro Nephrology Summit 2026 (France)
- Diabetic Nephropathy - KIDNEY MEET 2026 (UK)
- Diagnostic, Imaging and Radiation Techniques - Euro Nephrology Summit 2026 (France)
- Dialysis - KIDNEY MEET 2026 (UK)
- Diet for Kidney Health - Euro Nephrology Summit 2026 (France)
- Digital Health & Renal Biomarkers - NEPHROLOGY ASIA 2026 (UAE)
- Digital Health and Epidemiological Data Science - EPIDEMIOLOGY-2026 (Netherlands)
- Digital Therapeutics, Tele-Nephrology & Remote Patient Management - Nephrologists 2026 (France)
- Drugs for Kidney Diseases - Kidney Care 2026 (UK)
- Drugs used in the treatment of Kidney Diseases - Euro Nephrology Summit 2026 (France)
- Electrolyte & Fluid Balance in Kidney Disorders - NEPHROLOGY ASIA 2026 (UAE)
- Environmental and Occupational Nephrology - World Nephrology 2026 (Netherlands)
- Environmental Impacts on Kidney Health - NEPHROLOGY ASIA 2026 (UAE)
- Ethical Considerations in Kidney Transplantation - NEPHROLOGY ASIA 2026 (UAE)
- Ethics and Policy in Nephrology - NEPHROLOGY ASIA 2026 (UAE)
- Genetic and Rare Kidney Disorders - World Nephrology 2026 (Netherlands)
- Genomic Epidemiology and Precision Public Health - EPIDEMIOLOGY-2026 (Netherlands)
- Geriatric Nephrology - Kidney Care 2026 (UK)
- Geriatric Nephrology - NEPHROLOGY ASIA 2026 (UAE)
- Geriatric Nephrology: Managing the Aging Kidney - World Nephrology 2026 (Netherlands)
- Global Epidemiology and Disease Surveillance - EPIDEMIOLOGY-2026 (Netherlands)
- Glomerular Disease - Euro Nephrology Summit 2026 (France)
- Glomerular Diseases and Management - World Nephrology 2026 (Netherlands)
- Glomerular Diseases, Autoimmunity & Immune Kidney Disorders - Nephrologists 2026 (France)
- Health Systems and Policy Research - EPIDEMIOLOGY-2026 (Netherlands)
- Hematology in Kidney Health - KIDNEY MEET 2026 (UK)
- Hereditary Kidney Disorders - Euro Nephrology Summit 2026 (France)
- Hypertension & Kidney Health - World Nephrology 2026 (Netherlands)
- Hypertension and Kidney Health - KIDNEY MEET 2026 (UK)
- Hypertension associated with Kidney Diseases - Euro Nephrology Summit 2026 (France)
- Hypertension, Cardiovascular–Renal Axis & Vascular Health - Nephrologists 2026 (France)
- Immunomodulatory & Targeted Therapies for Glomerular Diseases - NEPHROLOGY ASIA 2026 (UAE)
- Infection and Immunity in Renal Diseases - World Nephrology 2026 (Netherlands)
- Infectious Diseases and Pandemic Preparedness - EPIDEMIOLOGY-2026 (Netherlands)
- Innovations in Dialysis, Wearable & Implantable Devices - Nephrologists 2026 (France)
- Innovations in Polycystic Kidney Disease Management - NEPHROLOGY ASIA 2026 (UAE)
- Innovative Dialysis Modalities - World Nephrology 2026 (Netherlands)
- Kidney and Bladder Cancer - Kidney Care 2026 (UK)
- Kidney Diseases & Diagnosis of Kidney Diseases - Kidney Care 2026 (UK)
- Kidney Failure - KIDNEY MEET 2026 (UK)
- Kidney Stones - Euro Nephrology Summit 2026 (France)
- Kidney Stones - KIDNEY MEET 2026 (UK)
- Kidney Transplantation - Kidney Care 2026 (UK)
- Kidney Transplantation - Euro Nephrology Summit 2026 (France)
- Kidney Transplantation - KIDNEY MEET 2026 (UK)
- Kidney Transplantation, Xenotransplantation & Organ Preservation - Nephrologists 2026 (France)
- Kidney Transplantation: Advances & Ethical Considerations - World Nephrology 2026 (Netherlands)
- Kidney-on-a-Chip for Drug Testing - NEPHROLOGY ASIA 2026 (UAE)
- Maternal and Child Health Epidemiology - EPIDEMIOLOGY-2026 (Netherlands)
- Maternal and Child Health Epidemiology - EPIDEMIOLOGY-2026 (Netherlands)
- Mental Health and Behavioral Epidemiology - EPIDEMIOLOGY-2026 (Netherlands)
- Mental Health in Nephrology Patients - World Nephrology 2026 (Netherlands)
- Metabolic Kidney Disorders & Electrolyte Imbalance Management - Nephrologists 2026 (France)
- Migration, Displacement, and Global Health - EPIDEMIOLOGY-2026 (Netherlands)
- Mineral and Bone Disorders in CKD - KIDNEY MEET 2026 (UK)
- Minimally Invasive Urologic Surgery & Robotic Innovations - Nephrologists 2026 (France)
- Nanotechnology in Kidney Therapeutics - NEPHROLOGY ASIA 2026 (UAE)
- Nephrology - Kidney Care 2026 (UK)
- Nephrology - Euro Nephrology Summit 2026 (France)
- Nephrology Nursing - Kidney Care 2026 (UK)
- Nephrology Nursing - KIDNEY MEET 2026 (UK)
- Nephrology Nursing and Allied Health Roles - World Nephrology 2026 (Netherlands)
- Nephrotic Syndrome - Euro Nephrology Summit 2026 (France)
- Non-Communicable Diseases: Prevention and Control - EPIDEMIOLOGY-2026 (Netherlands)
- Nutrigenomics and Personalized Diet in Kidney Health - NEPHROLOGY ASIA 2026 (UAE)
- Nutrition and Lifestyle in Kidney Health - World Nephrology 2026 (Netherlands)
- Nutrition and Public Health - EPIDEMIOLOGY-2026 (Netherlands)
- Occupational and Industrial Epidemiology - EPIDEMIOLOGY-2026 (Netherlands)
- Patient-Centered Care and Advocacy - World Nephrology 2026 (Netherlands)
- Pediatric and Geriatric Nephrology - KIDNEY MEET 2026 (UK)
- Pediatric Nephrology - Kidney Care 2026 (UK)
- Pediatric Nephrology - Euro Nephrology Summit 2026 (France)
- Pediatric Nephrology - NEPHROLOGY ASIA 2026 (UAE)
- Pediatric Nephrology & Rare Renal Genetic Disorders - Nephrologists 2026 (France)
- Pediatric Nephrology: Growing Concerns in Children - World Nephrology 2026 (Netherlands)
- Pharmacogenomics in Drug Metabolism & Kidney Function - NEPHROLOGY ASIA 2026 (UAE)
- Pharmacogenomics in Renal Therapeutics - NEPHROLOGY ASIA 2026 (UAE)
- Pharmacological Approaches in Kidney Disease - KIDNEY MEET 2026 (UK)
- Precision Medicine in Kidney Care - World Nephrology 2026 (Netherlands)
- Public Health Preparedness and Emergency Response - EPIDEMIOLOGY-2026 (Netherlands)
- Regenerative Kidney Therapies & Cellular Repair Technologies - Nephrologists 2026 (France)
- Regenerative Medicine and Kidney Tissue Engineering - NEPHROLOGY ASIA 2026 (UAE)
- Regenerative Medicine and Stem Cell Therapies - World Nephrology 2026 (Netherlands)
- Renal Nutrition - KIDNEY MEET 2026 (UK)
- Renal Nutrition and Metabolism - Kidney Care 2026 (UK)
- Renal Pathology & Immunology - Kidney Care 2026 (UK)
- Renal Pathology and Immunology - KIDNEY MEET 2026 (UK)
- Renal Precision Medicine & Genomic Risk Profiling - Nephrologists 2026 (France)
- Robotic Kidney Transplantation - KIDNEY MEET 2026 (UK)
- Robotic Surgery - Kidney Care 2026 (UK)
- Smart Home Dialysis Devices - NEPHROLOGY ASIA 2026 (UAE)
- Smart Nephro-Diagnostics & AI-Enabled Kidney Monitoring - Nephrologists 2026 (France)
- Social Determinants of Health and Health Equity - EPIDEMIOLOGY-2026 (Netherlands)
- Stages of Kidney Diseases - Euro Nephrology Summit 2026 (France)
- Stem Cell Research in Nephrology - NEPHROLOGY ASIA 2026 (UAE)
- Stem cells in Renal Disorders - Euro Nephrology Summit 2026 (France)
- Stem Cells in Renal Disorders - KIDNEY MEET 2026 (UK)
- Technological Advancements in Nephrology - Euro Nephrology Summit 2026 (France)
- The End Stage Renal Diseases & Chronic Kidney Diseases - Kidney Care 2026 (UK)
- Urinary Microbiome, Infection Dynamics & Host Defense - Nephrologists 2026 (France)
- Urologic Oncology: Targeted Therapies & Biomarker Breakthroughs - Nephrologists 2026 (France)
- Urology - KIDNEY MEET 2026 (UK)
- Urology / Urinary Tract Infections - Kidney Care 2026 (UK)
- Women’s Health and Pregnancy - KIDNEY MEET 2026 (UK)
